Pfizer seeks OTC switch for sildenafil in the UK

29 March 2017 - Deborah Wilkes

Archived

Pfizer is seeking to switch its erectile-dysfunction drug sildenafil citrate from prescription to non-prescription status in the UK, but the OTC version will not carry the Viagra brand name. The company told OTCToolbox it was exploring other markets in the European Union where this might be possible.

Click tags below for more information on topics:

MHRA PAGB

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: